Cigna Group (NYSE:CI) Releases Quarterly Earnings Results, Beats Estimates By $0.46 EPS

Cigna Group (NYSE:CI) posted its earnings results on Thursday. The health services provider reported $7.98 EPS for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46, Zacks reports. The company had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.83 earnings per share.

Here are the key takeaways from Cigna Group’s conference call:

• Positive Sentiment: Cigna reported third-quarter adjusted revenue of $73.8 billion and adjusted EPS of $7.98, and raised its 2026 adjusted EPS outlook to at least $30.60.
• Positive Sentiment: Specialty and Care Services earnings grew 15% year over year, supported by specialty pharmacy and distribution capabilities and strong adoption of lower-cost biosimilars and generics. Cigna Healthcare earnings also grew 15%, with medical costs elevated but stable and in line with pricing assumptions.
• Negative Sentiment: Evernorth Pharmacy Benefit Services faces 2027 pressure from industry-wide rebate compression and fewer employers covering GLP-1 drugs for weight loss; management expects PBS earnings to decline by a single-digit percentage. Signature adoption is expected to broaden in 2028, after the Cigna Healthcare fully insured launch in 2027.
• Positive Sentiment: Management expects at least 10% adjusted EPS growth in 2027 from an approximately $30 run-rate base, which reflects the ACA exchange exit and an estimated $200 million headwind. It also reaffirmed its long-term 10%–14% EPS growth framework and at least $45 of adjusted EPS by 2030.
• Positive Sentiment: Cigna expects its Accelerate to One modernization and productivity program to generate $3 billion in gross run-rate savings by 2030, with some savings reinvested in the business and some contributing to results.

Cigna Group Stock Performance

Cigna Group stock traded down $3.74 during mid-day trading on Thursday, reaching $301.67. 2,769,129 shares of the company traded hands, compared to its average volume of 1,519,686. The firm’s fifty day moving average is $285.48 and its two-hundred day moving average is $282.05. The company has a market capitalization of $79.71 billion, a price-to-earnings ratio of 9.70, a price-to-earnings-growth ratio of 1.03 and a beta of 0.25. Cigna Group has a fifty-two week low of $255.53 and a fifty-two week high of $318.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Adjusted earnings were $7.98 per share, ahead of analyst expectations, while revenue rose 6% year over year to about $73.7 billion. Strength in Cigna Healthcare and a favorable drug mix supported results. Article: Cigna Q3 Earnings Top Estimates on Cigna Healthcare Strength
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. The company also outlined long-term targets of 10%–14% adjusted EPS growth and about $50 billion in cumulative operating cash flow through 2030, alongside a $3 billion modernization and productivity initiative. Article: The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook
• Negative Sentiment: Reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier, and Cigna’s planned exit from ACA marketplace business is nearing. These factors may temper the reaction to the adjusted earnings beat and higher outlook. Article: Cigna raises financial outlook as ACA exit nears

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 617 shares of the business’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. UBS Group reissued a “buy” rating on shares of Cigna Group in a research report on Thursday, October 1st. Barclays boosted their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $336.40.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.